Evidence map›Paper›PMID 29712475›Full record

ArticleThe American journal of psychiatry2018

Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.

Martilias Farrell, Maya Lichtenstein, James J Crowley, Dawn M Filmyer, Gabriel Lázaro-Muñoz, Rita A Shaughnessy, Ian R Mackenzie, Veronica Hirsch-Reinshagen, Robert Stowe, James P Evans and 4 more

Abstract read
In one paragraph

Article in The American journal of psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Martilias FarrellFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Maya LichtensteinFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
James J CrowleyFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Dawn M FilmyerFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Gabriel Lázaro-MuñozFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Rita A ShaughnessyFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Ian R MackenzieFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Veronica Hirsch-ReinshagenFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Robert StoweFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
James P EvansFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Jonathan S BergFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Jin SzatkiewiczFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Richard C JosiassenFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.
Patrick F SullivanFrom the Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill; the Department of Neurology, Geisinger Health System, Wilkes-Barre, Pa.; Translational Neuroscience, Conshohocken, Pa.; the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston; the Department of Pathology and Laboratory Medicine and the Department of Psychiatry, University of British Columbia, Vancouver; and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm.

Funding

Finding causal variants within schizophrenia risk lociR01MH106611 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SZATKIEWICZ, JIN PENG · 2015 to 2019
$3.3M
1/7 Psychiatric Genomics Consortium: Finding actionable variationU01MH109528 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2016 to 2020
$2.5M
Behavioral Pharmacology of Serotonin Inverse AgonistsR01DA014673 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI WALKER, ELLEN ANN · 2002 to 2006
$1.4M
Return of Results from Psychiatric Genomics Research: Attitudes and BarriersR00HG008689 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI LAZARO-MUNOZ, GABRIEL, STORCH, ERIC A. · 2017 to 2019
$905k
The Genomics of Highly Treatment Resistant SchizophreniaK01MH108894 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FARRELL, MARTILIAS STEPHEN · 2016 to 2019
$567k
The MIR137 region in schizophrenia: genomics, variant discovery & associationR21MH099370 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F, SZATKIEWICZ, JIN PENG · 2013 to 2014
$418k
NHGRI NIH HHS R00 HG008689NIMH NIH HHS K01 MH108894NIMH NIH HHS R01 MH106611NIMH NIH HHS R21 MH099370NIMH NIH HHS U01 MH109528
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

22q11 Deletion SyndromeAbnormalities, MultipleAdultAlzheimer DiseaseBrainChromosome DeletionChromosome DuplicationComorbidityDevelopmental DisabilitiesDNA Copy Number VariationsDown SyndromeDrug ResistanceGenomeHumansHuntington DiseaseMale22q11 DSGeneticsHuntington’s diseaseSchizophrenia

Identifiers

PMID29712475
PMCPMC5935124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.